688098 Stock Overview
Engages in the research, development, production, and sale of veterinary biological products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Shanghai Shen Lian Biomedical Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.63 |
| 52 Week High | CN¥7.58 |
| 52 Week Low | CN¥3.63 |
| Beta | 0.65 |
| 1 Month Change | 7.44% |
| 3 Month Change | 44.36% |
| 1 Year Change | -23.09% |
| 3 Year Change | -48.01% |
| 5 Year Change | -66.43% |
| Change since IPO | -84.71% |
Recent News & Updates
Shareholder Returns
| 688098 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.7% | -1.0% | 0.4% |
| 1Y | -23.1% | -3.0% | 12.3% |
Return vs Industry: 688098 underperformed the CN Pharmaceuticals industry which returned -4.4% over the past year.
Return vs Market: 688098 underperformed the CN Market which returned 9.8% over the past year.
Price Volatility
| 688098 volatility | |
|---|---|
| 688098 Average Weekly Movement | 8.7% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 688098 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688098's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 389 | Xu Gao | www.slbio.com.cn |
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
Shanghai Shen Lian Biomedical Corporation Fundamentals Summary
| 688098 fundamental statistics | |
|---|---|
| Market cap | CN¥2.31b |
| Earnings (TTM) | -CN¥19.73m |
| Revenue (TTM) | CN¥310.36m |
7.4x
P/S Ratio-117.2x
P/E RatioIs 688098 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688098 income statement (TTM) | |
|---|---|
| Revenue | CN¥310.36m |
| Cost of Revenue | CN¥117.65m |
| Gross Profit | CN¥192.71m |
| Other Expenses | CN¥212.44m |
| Earnings | -CN¥19.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.048 |
| Gross Margin | 62.09% |
| Net Profit Margin | -6.36% |
| Debt/Equity Ratio | 0% |
How did 688098 perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield-78%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 05:16 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Shen Lian Biomedical Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiarui Lu | Guosen Securities Co., Ltd. |